# FDA Inspection 1181705 - OneBlood, Inc. - October 12, 2022

Source: https://www.keypedia.com/records/fda_inspections/oneblood-inc/f03faa66-edb2-4ca7-9485-e0c9a39e5dac
Source feed: FDA_Inspections

> FDA Inspection 1181705 for OneBlood, Inc. on October 12, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1181705
- Company Name: OneBlood, Inc.
- Inspection Date: 2022-10-12
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1181705 - 2022-10-12](https://www.keypedia.com/records/fda_inspections/oneblood-inc/6667b56b-2d2a-4495-b652-febb59555fb2)
- [FDA Inspection 1036381 - 2017-11-20](https://www.keypedia.com/records/fda_inspections/oneblood-inc/55e79bc4-defa-4390-a62b-3c41c8087539)
- [FDA Inspection 987796 - 2016-06-20](https://www.keypedia.com/records/fda_inspections/oneblood-inc/bcc14009-1658-4fd9-a0ba-7747aa684c52)
- [FDA Inspection 890247 - 2014-08-07](https://www.keypedia.com/records/fda_inspections/oneblood-inc/af128640-a0a9-40bb-927d-180fa51def4a)
- [FDA Inspection 804618 - 2012-10-24](https://www.keypedia.com/records/fda_inspections/oneblood-inc/9bb41587-60f4-4272-b73c-b9a4535d4858)

Company: https://www.keypedia.com/companies/oneblood-inc/487fb6f5-be31-47f2-bb0d-0202b6f929bc

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d